Evidence map›Paper›PMID 35958403›Full record

ArticleFrontiers in cardiovascular medicine2022

Prognostic value of the PDW/HDL-C ratio in patients with chest pain symptoms and coronary artery calcification.

Ya-Jing Qiu, Jun-Yi Luo, Fan Luo, Xin-Xin Tian, Lu Zeng, Zhuo-Ran Zhang, Xiao-Mei Li, Yi-Ning Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ya-Jing QiuDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Jun-Yi LuoDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Fan LuoDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Xin-Xin TianDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Lu ZengDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Zhuo-Ran ZhangDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Xiao-Mei LiDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Yi-Ning YangDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Xinjiang Medical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Platelet-related parameters and HDL-C have been regarded as reliable and alternative markers of coronary heart disease (CHD) and the independent predictors of cardiovascular outcomes. PDW is a simple platelet index, which increases during platelet activation. Whether the PDW/HDL-C ratio predicts major adverse cardiovascular and cerebrovascular events (MACCEs) in patients who complained of chest pain and confirmed coronary artery calcification remains to be investigated. This study aimed to investigate the prognostic value of the PDW/HDL-C ratio in patients with chest pain symptoms and coronary artery calcification. Methods: A total of 5,647 patients with chest pain who underwent coronary computer tomography angiography (CTA) were enrolled in this study. Patients were divided into two groups according to their PDW/HDL-C ratio or whether the MACCE occurs. The primary outcomes were new-onset MACCEs, defined as the composite of all-cause death, non-fatal MI, non-fatal stroke, revascularization, malignant arrhythmia, and severe heart failure. Results: All patients had varying degrees of coronary calcification, with a mean CACS of 97.60 (22.60, 942.75), and the level of CACS in the MACCEs group was significantly higher than that in non-MACCE (P<0.001). During the 89-month follow-up, 304 (5.38%) MACCEs were recorded. The incidence of MACCEs was significantly higher in patients with the PDW/HDL-C ratio > 13.33. The K-M survival curves showed that patients in the high PDW/HDL-C ratio group had significantly lower survival rates than patients in the low PDW/HDL-C ratio group (log-rank test: Conclusion: The higher PDW/HDL-C ratio was independently associated with the increasing risk of MACCEs in patients with chest pain symptoms and coronary artery calcification. In patients with moderate calcification, mild coronary artery stenosis, and CAD verified by CTA, the incidence of MACCEs increased significantly in the PDW/HDL-C ratio > 13.33 group. Adding the PDW/HDL-C ratio to the traditional model provided had an incremental prognostic value for MACCEs.

Indexed as

chest paincoronary artery calcificationcoronary heart disease (CHD)major adverse cardiovascular and cerebrovascular events (MACCEs)PDW/HDL-C ratio

Identifiers

PMID35958403
PMCPMC9357987
OpenAlexW4287147092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.